Pharma Lecture Theatre

The Pharma Lecture Theatre

pharma

Including the Pharma Outsourcing Best Practices Panel and the Abou-Gharbia Lecture

This theatre is dedicated to the trends, challenges and outlook of the pharmaceutical industry. You can expect first-hand information on ongoing R&D projects and exchange with leading industry experts. 

Look forward especially to Dr Magid Abou-Gharbia, Associate Dean for Research, Director, Moulder Center for Drug Discovery Research and Laura H. Carnell Professor, Temple University, Philadelphia, who will speak exclusively at Chemspec Europe 2019.

The Pharma Outsourcing Best Practices Panel

Chaired by Dr Magid Abou-Gharbia

The session will discuss approaches to developing global outsourcing strategies, identifying outsourcing partners, identifying approaches to mitigate risks, and addressing challenges associated with outsourcing and how to effectively manage partnerships.

The Panel session will be of interest to a wide audience from Pharma, Crop Protection and Chemical companies, CROs and CMOs that are or will be engaged in contract research and custom synthesis of Active Pharmaceutical Ingredients (API). 

Moderators

  • Dr Magid Abou-Gharbia, Associate Dean for Research Director, Moulder Center for Drug Discovery Research, Temple University, Philadelphia, PA, USA (Senior VP, Wyeth Pharmaceuticals)
  • Dr Rudolf Hanko, Board Member and former CEO, Siegfried

Speakers 

  • Susan Billings, Ph.D., VP Global Business Development, AMRI
  • Rebecca Bishop, Associate Director Manufacturing Procurement, Eli Lilly
  • Stephan Kutzer, Ph.D., CEO, Alcami,
  • Harry Rathore, Ph.D., CEO, Callery
  • Prashant Savle, Ph.D., Director Commercialization Global Procurement, Merck
  • Tom Scrase, Ph.D., Assistant Director Business Development, Johnson Matthey
  • Marianne Späne, Executive VP Global Business Development, Siegfried
  • Robert Waltermire, Ph.D., VP Head Chemical & Synthetic Development, Global Product Development & Supply, Bristol Myers Squibb

Speaker Profiles »

The Abou-Gharbia Lecture 2019

Organised by Dr Magid Abou-Gharbia, Moulder Center for Drug Discovery Research

Challenges Facing the Pharmaceutical Industry in Today’s Environment

Pharmaceutical industry is currently undergoing an unprecedented difficult time and is facing enormous challenges. These challenges include industry tarnished image, declining efficiencies, patent expiration of key drugs, fierce price competition from generics, mergers and acquisitions and high regulatory hurdles. These challenges have been further exacerbated by the current economic downturn and the US healthcare initiative. In order to face the current grim realities, Pharmaceutical companies has adopted new strategies aimed at restoring public trust and confidence, addressing declining productivity and cutting cost while ensuring bringing steady stream of innovative therapeutics to patients.

The lecture will highlight:

  • Current challenges facing pharmaceutical industry
  • Facts surrounding generic drugs and answering patient key question “are generic drugs as safe and effective as brand name drugs?
  • Current approaches adopted by pharmaceutical industry to ensure their continuing growth and sustainability through the discovery of innovative therapeutics in the three pharmaceutical platforms: small molecule, biologics and vaccines.  

Dr Magid Abou-Gharbia

Associate Dean for Research at Temple University

CSE17 PharmaPanel AbouGharbia

Dr Abou-Gharbia is currently the Associate Dean for Research, Professor of Medicinal Chemistry and Director of the Moulder Center for Drug Discovery Research (MCDDR) at the School of Pharmacy, Temple University, Philadelphia, PA. 

Speaker Profile »


Presentations at the Pharma Lecture Theatre include:

WEDNESDAY, JUNE 26

9:30
10:30
Challenges Facing the Pharmaceutical Industry in Today’s Environment
Dr. Magid Abou-Gharbia Lecture
10:45
11:15
Homogeneous catalysis for ester hydrogenation
Garazi Talaver, Johnson Matthey
11:30
12:00
Overview of Kodak Specialty Chemicals
Dr. Rajiv Balasubramanian, Kodak Specialty Chemicals
12:15
12:45
Particle Properties and Particle Design from an API supplier’s view. The interaction of API CDMO and formulation SMEs to meet customer expectations
Dr. Michael Levis, Siegfried
13:00
13:30
Highly Potent API (HPAPI): Risk-Based Development and Manufacture
Dr. David Molyneux, Alcami
14:00
15:00
The Pharma Outsourcing Best Practices Panel
15:15
15:45
Vertellus Life Science Overview
Dr. Glenn Carroll, Vertellus
16:00
16:30
Single and multistage extraction for flow and batch chemistry applications
Dr. Andrea Adamo, Zaiput
16:30
17:00
Upgrading production capacity through inherently safer technology with Corning® Advanced-Flow™ Reactors for continuous manufacturing
Dr. Guillaume Gauron, Corning SAS

THURSDAY, JUNE 27

9:30
10:00
Biocatalysis for API and chemicals synthesis
Dr. Audrey Robic, Proteus
10:15
10:45
The use and benefits of nanomaterials in dental applications
Dr. Nora Reinhardt, Mathym SAS
11:00
12:00
The Pharma Outsourcing Best Practices Panel
12:15
12:45
Catalyst for enantioselective synthesis
Dr. Masahito Watanabe, Kanto Chemical
13:00
13:30
Handling Hazardous Reactions
Dr. Joerg Jung, AMRI
13:45
14:15
Cost Effective Tertiary Solution for the Removal of COD and APIs from Wastewater
Joseph Weston, Arvia Technology
14:30
15:00
Continuous formation of micro- and nanocarriers with controlled properties using microreaction technology
Dr. Anna Musyanovych, Fraunhofer
15:15
15:45
Highly Potent API’s - from clinical to commercial manufacturing
Dr. Nicola Glubellina, Dishman Europe

Please note that the programme is subject to change and will be updated continuously in the run up to the conference.

Aktuelles